November 17th, 2026Real-World Data Support Cemiplimab Efficacy in Advanced NSCLCIn this Q&A, Jesús Corral Jaime, MD, discusses real-world CEMI-LUNG data on cemiplimab in advanced NSCLC presented at the ESMO 2026 Congress.Read more
November 16th, 2026FDA Approves Dexmedetomidine Sublingual Film as At-Home Agitation TherapyFDA approves dexmedetomidine sublingual film for at-home use in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.Read more
November 13th, 2026AI, Disparities, and Payer Readiness in CLL Care: Kirsten Axelsen, MSIn this part 2, Kirsten Axelsen, MS, discusses racial disparities, AI in prior authorization, and payers’ readiness for the next wave of CLL therapies.Read more
November 13th, 2026Where CLL Care Falls Short of the Science: Kirsten Axelsen, MSKirsten Axelsen, MS, discusses gaps in biomarker testing, nonmedical barriers, and utilization management from a new report on access to CLL care.Read more